Insights

Innovative CNS Treatments NeurOp specializes in developing cutting-edge medicines targeting central nervous system disorders, creating opportunities to collaborate with healthcare providers and research institutions seeking advanced therapies for conditions like stroke, severe pain, and depression.

Strong Research Funding Supported by multi-year NIH funding, NeurOp has solid financial backing for its drug development programs, indicating a stable platform for partnership and licensing deals with pharmaceutical companies seeking promising CNS candidates.

Strategic Collaborations Existing partnership with Bristol-Myers Squibb highlights opportunities to expand collaborations or license promising compounds such as NP10679 to larger pharma firms interested in novel NMDA receptor inhibitors.

Targeted Neurotechnology Focusing on the GluN2B subunit of NMDA receptors offers a differentiated scientific approach, which could attract investment and licensing from companies exploring innovative neurotherapeutic platforms.

Emerging Market Potential As a clinical-stage biotech with a small team and early revenue, NeurOp is positioned for growth with strategic partners in the burgeoning neuroscience market, creating opportunities for joint ventures, co-development, and acquisition discussions.

NeurOp, Inc. Tech Stack

NeurOp, Inc. uses 8 technology products and services including MySQL, Font Awesome, jQuery Migrate, and more. Explore NeurOp, Inc.'s tech stack below.

  • MySQL
    Database
  • Font Awesome
    Font Scripts
  • jQuery Migrate
    Javascript Libraries
  • Google Maps
    Maps
  • Google Analytics
    Web Analytics
  • SiteOrigin Widgets Bundle
    Web Platform Extensions
  • SiteOrigin Page Builder
    Web Platform Extensions
  • Apache
    Web Servers

NeurOp, Inc.'s Email Address Formats

NeurOp, Inc. uses at least 1 format(s):
NeurOp, Inc. Email FormatsExamplePercentage
FLast@neuropinc.comJDoe@neuropinc.com
40%
First.Last@neuropinc.comJohn.Doe@neuropinc.com
10%
FLast@neuropinc.comJDoe@neuropinc.com
40%
First.Last@neuropinc.comJohn.Doe@neuropinc.com
10%

Frequently Asked Questions

Where is NeurOp, Inc.'s headquarters located?

Minus sign iconPlus sign icon
NeurOp, Inc.'s main headquarters is located at 58 Edgewood Avenue, NE, Suite 122 Atlanta, Georgia 30303, US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is NeurOp, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact NeurOp, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is NeurOp, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
NeurOp, Inc.'s official website is neuropinc.com and has social profiles on LinkedInCrunchbase.

How much revenue does NeurOp, Inc. generate?

Minus sign iconPlus sign icon
As of October 2025, NeurOp, Inc.'s annual revenue is estimated to be $950K.

What is NeurOp, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
NeurOp, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does NeurOp, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2025, NeurOp, Inc. has approximately 6 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Head Of Chemistry: L. L.Co-Founder, Board Of Directors, Sab: R. D.Head, Corporate Development: V. L.. Explore NeurOp, Inc.'s employee directory with LeadIQ.

What industry does NeurOp, Inc. belong to?

Minus sign iconPlus sign icon
NeurOp, Inc. operates in the Biotechnology Research industry.

What technology does NeurOp, Inc. use?

Minus sign iconPlus sign icon
NeurOp, Inc.'s tech stack includes MySQLFont AwesomejQuery MigrateGoogle MapsGoogle AnalyticsSiteOrigin Widgets BundleSiteOrigin Page BuilderApache.

What is NeurOp, Inc.'s email format?

Minus sign iconPlus sign icon
NeurOp, Inc.'s email format typically follows the pattern of FLast@neuropinc.com. Find more NeurOp, Inc. email formats with LeadIQ.

When was NeurOp, Inc. founded?

Minus sign iconPlus sign icon
NeurOp, Inc. was founded in 2001.

NeurOp, Inc.

Biotechnology ResearchUnited States2-10 Employees

NeurOp, Inc. is a clinical-stage biotechnology company developing new medicines for central nervous system disorders, including stroke, severe pain, subarachnoid hemorrhage (SAH), and treatment-resistant depression. Its technology targets the GluN2B subunit of neuronal NMDA receptors and its potential therapeutic benefit. 

Multi-year funding from the NIH supports NeurOp's research and development programs for NP10679, its drug candidate for the prevention of ischemic damage during a stroke or subarachnoid hemorrhage (SAH) and severe pain. For more information, please visit www.neuropinc.com.

Section iconCompany Overview

Headquarters
58 Edgewood Avenue, NE, Suite 122 Atlanta, Georgia 30303, US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2001
Employees
2-10

Section iconFunding & Financials

  • $1M$10M

    NeurOp, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    NeurOp, Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.